| scholarly article | Q13442814 |
| P2093 | author name string | T L Whiteside | |
| A D Donnenberg | |||
| W Gooding | |||
| G G Kim | |||
| V S Donnenberg | |||
| P2860 | cites work | New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population | Q28186126 |
| Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants | Q29619458 | ||
| Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer | Q29619483 | ||
| Natural killer cells in antiviral defense: function and regulation by innate cytokines | Q33652468 | ||
| Cytotoxic T cells | Q34485256 | ||
| NKT cells - conductors of tumor immunity? | Q34547180 | ||
| Natural killer cell receptor signaling | Q35145778 | ||
| Measuring T cell-mediated cytotoxicity using fluorogenic caspase substrates | Q35212674 | ||
| Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma | Q35229190 | ||
| NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer | Q36399548 | ||
| Natural killer cell developmental pathways: a question of balance. | Q36427341 | ||
| Analysis of longitudinal data: random coefficient regression modelling | Q36728083 | ||
| Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation | Q37371294 | ||
| Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay | Q37906873 | ||
| A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology | Q39513036 | ||
| Role of human natural killer cells in health and disease. | Q40381629 | ||
| A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry | Q40950815 | ||
| The role of natural killer cells in immune surveillance of cancer | Q40952521 | ||
| Caspase activity is not sufficient to execute cell death | Q43596172 | ||
| Flow cytometric assay for the simultaneous analysis of cell-mediated cytotoxicity and effector cell phenotype | Q43746528 | ||
| Direct visualisation and quantification of cellular cytotoxicity using two colour flourescence | Q44302050 | ||
| Cell‐mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexinV/propidium iodide colabeling by fluorosphere‐adjusted counts on three‐color flow cytometry | Q44623666 | ||
| Multiparametric analysis of apoptosis by flow and image cytometry | Q44771809 | ||
| Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression | Q46111594 | ||
| Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. | Q51186094 | ||
| How do cytotoxic lymphocytes kill their targets? | Q57720900 | ||
| A new immunodeficiency disorder in humans involving NK cells | Q59094886 | ||
| Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus | Q61140487 | ||
| Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence | Q68719190 | ||
| Clinical application of a whole blood assay for human natural killer (NK) cell activity | Q71761086 | ||
| Flow cytometric analysis of natural killer cell function as a clinical assay | Q72066705 | ||
| A new four-color flow cytometric assay to detect apoptosis in lymphocyte subsets of cultured peripheral blood cells | Q73777245 | ||
| Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates | Q77580234 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | cytotoxicity | Q246181 |
| flow cytometry | Q1141429 | ||
| P304 | page(s) | 51-66 | |
| P577 | publication date | 2007-06-28 | |
| P1433 | published in | Journal of Immunological Methods | Q15755939 |
| P1476 | title | A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay | |
| P478 | volume | 325 |
| Q38694446 | A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity. |
| Q36222619 | A High-Throughput Assay for Screening of Natural Products that Enhanced Tumoricidal Activity of NK Cells |
| Q27312227 | A Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image Cytometry |
| Q34634251 | Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects |
| Q28392663 | An F1-extended one-generation reproductive toxicity study in Crl:CD(SD) rats with 2,4-dichlorophenoxyacetic acid |
| Q28477924 | An efficient vector system to modify cells genetically |
| Q37535232 | Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies |
| Q36916476 | Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells |
| Q48012057 | Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions |
| Q33507092 | Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection |
| Q36677954 | Brief Report: Enhanced Allogeneic Cellular Responses to Mismatched HLA-B Antigens Results in More Efficient Killing of HIV Infected Cells. |
| Q34707604 | CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies |
| Q36986153 | CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells |
| Q35674757 | CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis |
| Q38463939 | Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma |
| Q53057832 | Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells. |
| Q33676231 | Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells |
| Q45233206 | Development and application of a multiplexable flow cytometry-based assay to quantify cell-mediated cytolysis |
| Q49237902 | Dynamic Analysis of Human Natural Killer Cell Response at Single-Cell Resolution in B-Cell Non-Hodgkin Lymphoma |
| Q36295912 | EWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma family of tumors |
| Q64136298 | Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis |
| Q61124859 | Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins |
| Q44553005 | Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway. |
| Q39617666 | Evaluating vaccinia virus cytokine co-expression in TLR GKO mice. |
| Q43537337 | Evaluation of NK cell function by flowcytometric measurement and impedance based assay using real-time cell electronic sensing system |
| Q39431665 | Evaluation of a flow cytometry-based assay for natural killer cell activity in clinical settings |
| Q39498305 | Granzyme B-mRNA expression by equine lymphokine activated killer (LAK) cells is associated with the induction of apoptosis in target cells |
| Q36767899 | HIV-1-Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection. |
| Q38835585 | HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome |
| Q92016322 | Highly efficient serum-free manipulation of miRNA in human NK cells without loss of viability or phenotypic alterations is accomplished with TransIT-TKO |
| Q41654263 | IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression |
| Q35995167 | IL-15, in synergy with RAE-1ɛ, stimulates TCR-independent proliferation and activation of CD8(+) T cells |
| Q37040481 | IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients |
| Q34585798 | IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells |
| Q39833293 | Identification of an HLA-A*0201-restrictive CTL epitope from MUC4 for applicable vaccine therapy |
| Q49961097 | Immune evasion via PD-1/PD-L1 on NK-cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL. |
| Q47126440 | Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells |
| Q41731948 | Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses. |
| Q38913090 | Methods to evaluate cytotoxicity and immunosuppression of combustible tobacco product preparations |
| Q37186175 | Multispectral imaging of hematopoietic cells: where flow meets morphology |
| Q52777818 | Natural Killer Cell Subsets and Their Functional Activity in Behçet's Disease. |
| Q42378441 | Natural killer cell activity for IFN-gamma production as a supportive diagnostic marker for gastric cancer |
| Q34027777 | New flow cytometric assays for monitoring cell-mediated cytotoxicity |
| Q39596000 | Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia |
| Q28972367 | Novel innate cancer killing activity in humans |
| Q38733548 | Osteopontin has a protective role in prostate tumor development in mice |
| Q60907662 | PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8 T cell Induced Death |
| Q40098267 | Programmed death 1 is highly expressed on CD8+CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to EBV. |
| Q28744503 | Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers |
| Q48001813 | Reduced frequency of CD56 dim CD16 pos natural killer cells in pediatric systemic inflammatory response syndrome/sepsis patients. |
| Q50262423 | Single-colour flow cytometric assay to determine NK cell-mediated cytotoxicity and viability against non-adherent human tumor cells |
| Q35780315 | Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer |
| Q36274723 | Substituting whole grains for refined grains in a 6-wk randomized trial has a modest effect on gut microbiota and immune and inflammatory markers of healthy adults |
| Q51063063 | Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer. |
| Q39985240 | Tailored chemokine receptor modification improves homing of adoptive therapy T cells in a spontaneous tumor model |
| Q33872482 | Targeting CD137 enhances the efficacy of cetuximab. |
| Q59360845 | The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine |
| Q34419059 | Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures. |
| Q35212162 | Tracking Immune Cell Proliferation and Cytotoxic Potential Using Flow Cytometry |
| Q37002943 | Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. |
| Q27312822 | Trypanosoma brucei Co-opts NK Cells to Kill Splenic B2 B Cells |
| Q55129555 | VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells. |
| Q35883106 | Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15. |
Search more.